Heart Failure Care and Post-Hospital Outcomes in Northwestern Tanzania
References
- Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21:717–734. DOI: 10.1038/s41569-024-01046-6
- Darvish M, Shakoor A, Feyz L, Schaap J, van Miegham NM, de Boer RA, et al. Heart failure: Assessment of the global economic burden. Eur Heart J. 2025;46(31):3069–3078. DOI: 10.1093/eurheartj/ehaf323
- Chen Q-F, Chen L, Katsouras CS, Liu C, Shi J, Liang D, et al. Global burden of heart failure and its underlying causes in 204 countries and territories, 1990–2021. Eur Heart J Qual Care Clin Outcomes. 2025;11(4):493–509. DOI: 10.1093/ehjqcco/qcae110
- Fonarow GC, Ahmad FS, Ahmad T, Alexander KM, Baker WL, Bozkurt B, et al. HF STATS 2025: Heart failure epidemiology and outcomes statistics an updated 2025 report from the Heart Failure Society of America. J Card Fail. 2025. DOI: 10.1016/j.cardfail.2025.07.007
- G-CHF Investigators. Global variations in heart failure etiology, management, and outcomes. JAMA. 2023;329(19):1650–1661. DOI: 10.1001/jama.2023.5942
- Karaye KM, Dokainish H, ElSayed A, Mondo C, Damasceno A, Silwa K, et al. Clinical profiles and outcomes of heart failure in five African countries: Results from INTER-CHF study. Glob Heart. 2021: 16(1):50. DOI: 10.5334/gh.940
- World Health Organization. WHO package of essential noncommunicable (PEN) disease interventions for primary health care. Geneva: World Health Organization; 2020.
- NCDI Poverty Network. PEN-Plus clinical tools and programmatic standards [Internet]. Boston, MA: NCDI Poverty Network; 2024 [cited 2026 Jan 22]. Available from:
https://www.ncdipoverty.org/pen-plus-clinical-tools-and-programmatic-standards - World Health Organization Regional Office for Africa. PEN-Plus: A regional strategy to address severe noncommunicable diseases at first-level referral health facilities in the African Region. Brazzaville (Republic of the Congo): WHO Regional Office for Africa; 2022. Report No.: AFR/RC72/4.
- Siddikatou D, Mandeng Ma Linwa E, Ndobo V, Nkoke C, Mouliom S, Ndom MS, et al. Heart failure outcomes in Sub-Saharan Africa: A scoping review of recent studies conducted after the 2022 AHA/ACC/HFSA guideline release. BMC Cardiovasc Disord. 2025;25:302. DOI: 10.1186/s12872-025-04756-y
- McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med. 1971;285(26):1441–1446. DOI: 10.1056/NEJM197112232852601
- Kingery JR, Yango M, Wajanga B, Kalokola F, Kathairya J, et al. Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study. Int J Cardiol. 2017;243:311–317. DOI: 10.1016/j.ijcard.2017.05.025
- Ameh S, Akeem BO, Ochimana C, Oluwasanu AO, Mohamed SF, Okello S, et al. A qualitative inquiry of access to and quality of primary healthcare in seven communities in East and West Africa (SevenCEWA): Perspectives of stakeholders, healthcare providers and users. BMC Fam Pract. 2021;22:45. DOI: 10.1186/s12875-021-01394-z
- Dzudie A, Barche B, Nkoke C, Ngatchuesi VG, Ndom MS, Mouliom S, et al. Survival rate and predictors of 36-month mortality in patients with heart failure in sub-Saharan Africa: Insights from the Douala Heart Failure Registry (Do-HF). Cardiovasc Diagn Ther. 2022;12(7):577–588. DOI: 10.21037/cdt-22-166
- Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294(10):1240–1247. DOI: 10.1001/jama.294.10.1240
- Greene SJ, Kittipibul V, Dunlay SM. Overcoming the risk-treatment paradox: Prescribing GDMT for severe heart failure. JACC: Heart Fail. 2025;13(4):628–630. DOI: 10.1016/j.jchf.2025.01.014
- Hau DK, Ambrose EE, Smart LR, Kayange NM, Peck RN. Linkage to care intervention to improve post-hospital outcomes among children with sickle cell disease in Tanzania: A pilot study. J Pediatr (Rio J). 2021;232:290–293.e1.
- Sharma M, Ying R, Tarr G, Barnabas R. Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa. Nature. 2015;528:S77–S85. DOI: 10.1038/nature16044
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627–3639. DOI: 10.1093/eurheartj/ehad195
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e895–e1032. DOI: 10.1161/CIR.0000000000001063
- Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Filippatos G, Gustafsson F, et al. Management of worsening heart failure with reduced ejection fraction: JACC focus seminar 3/3. JACC. 2023;82(6): 559–571. DOI: 10.1016/j.jacc.2023.04.057
- Patolia H, Khan MS, Fonarow GC, Butler J, Greene SJ. Implementing guideline-directed medical therapy for heart failure: JACC focus seminar 1/3. JACC. 2023;82(6):529–543. DOI: 10.1016/j.jacc.2023.03.430
- Jalloh MB, Averbuch T, Kulkarni P, Granger CB, Januzzi JL, Zannad F, et al. Bridging treatment implementation gaps in patients with heart failure: JACC focus seminar 2/3. JACC. 2023;82(6):544–558. DOI: 10.1016/j.jacc.2023.05.050
- Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938–1952. DOI: 10.1016/S0140-6736(22)02076-1
- Keshvani N, Rizvi SK, Khashami F, Jain AK, Coellar JD, Bustillo-Rubio M, et al. Rationale, design, and baseline characteristics of the polypill for heart failure with reduced ejection fraction (POLY-HF) trial. J Card Fail. 2025;32(7):1199–1209. DOI: 10.1016/j.cardfail.2025.10.008
- Agarwal A, Devarajan R, Balbale S, Chopra A, Prabhakaran D, Huffman MD, et al. Heart failure with reduced ejection fraction polypill implementation strategy in India: A convergent parallel mixed methods study. Glob Heart. 2024;19(1):69. DOI: 10.5334/gh.1348
DOI: https://doi.org/10.5334/gh.1593 | Journal eISSN: 2211-8179
Language: English
Page range: 77 - 77
Submitted on: Jun 1, 2026
Accepted on: Oct 2, 2026
Published on: Oct 26, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
© 2026 Fredrick Kalokola, Bahati K. Wajanga, Mabula Deodatus, Eva Mujuni, Patrick Mayanja, David Majule, Andrew Luhanga, Evarist B. Msaki, Audax Malulu, Mariam Goba, Fortunatus Nestory, Jimmyson Masinga, Larry A. Allen, Priya B. Shete, Jeffrey Olgin, Robert Peck, Cody Cichowitz, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.